CSIG-24. miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2
Sign Up to like & getrecommendations! Published in 2018 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noy148.190
Abstract: Glioblastoma (GBM) patients currently face poor survival outcomes with an average survival period of less than 15 months, while only 3–5% of patients survive longer than 36 months. Although the mechanisms of tumorigenesis are still… read more here.
Keywords: mir 575; gbm; gbm patients; expression ... See more keywords